NEUX TECHNOLOGIES, INC. – Trademark Portfolio
Entity Type: 03
NEUX TECHNOLOGIES, INC. holds 6 U.S. trademarks filed with the United States Patent and Trademark Office (USPTO), with a strong focus on Class 10 (Medical Apparatus) — 4 filings in this category. The portfolio also extends into Class 35 (Advertising & Business) across 3 Nice Classification classes. Currently, 4 trademarks are registered and 1 is pending. Notable registered marks include NEUX, NXPRO, and INTERACTIVE NEUROMUSCULAR STIMULATION. The owner is based in West Palm Beach, FL.
640 Clematis Street
Suite 547
West Palm Beach, FL 33402
Showing of trademarks Trademarks
Trademark Classifications
NEUX TECHNOLOGIES, INC.'s trademark portfolio spans 3 Nice Classification classes, reflecting the scope of goods and services protected under their brand portfolio.
Advertising; business management; business administration; office functions
Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes
Frequently Asked Questions
How many trademarks does NEUX TECHNOLOGIES, INC. have?
NEUX TECHNOLOGIES, INC. has 6 U.S. trademarks filed with the USPTO. Of these, 4 registered, 1 pending, 1 abandoned.
What trademark classes does NEUX TECHNOLOGIES, INC. file in?
NEUX TECHNOLOGIES, INC. files trademarks across 3 Nice Classification classes. The most active classes are Class 10 (Medical Apparatus), Class 35 (Advertising & Business), Class 5 (Pharmaceuticals). Class 10 covers surgical, medical, dental and veterinary apparatus and instruments.
What are NEUX TECHNOLOGIES, INC.'s most well-known trademarks?
NEUX TECHNOLOGIES, INC.'s registered trademark portfolio includes well-known marks such as NEUX, NXPRO, and INTERACTIVE NEUROMUSCULAR STIMULATION. These are among 4 currently registered trademarks in the portfolio.
What is NEUX TECHNOLOGIES, INC.'s trademark registration success rate?
NEUX TECHNOLOGIES, INC. has a 80% trademark registration rate, with 4 out of 5 resolved applications resulting in successful registration. Currently, 1 application is pending review.